Versor Investments’s Charles River Laboratories CRL Stock Holding History

Versor Investments’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,802	Closed	-$559K	–	167
2025 Q4	$559K	Sell	2,802 -3,086	-52%	-$560K	0.09%	289
2025 Q3	$921K	Buy	+5,888	New	+$935K	0.17%	137
2025 Q1	–	Sell	-5,927	Closed	-$1.09M	–	745
2024 Q4	$1.09M	Buy	+5,927	New	+$1.14M	0.19%	134
2024 Q3	–	Sell	-5,740	Closed	-$1.19M	–	794
2024 Q2	$1.19M	Buy	+5,740	New	+$1.3M	0.22%	113
2024 Q1	–	Sell	-3,088	Closed	-$730K	–	716
2023 Q4	$730K	Sell	3,088 -1,202	-28%	-$236K	0.15%	215
2023 Q3	$841K	Buy	+4,290	New	+$881K	0.17%	152
2023 Q1	–	Sell	-4,457	Closed	-$971K	–	735
2022 Q4	$971K	Buy	4,457 +3,257	+271%	+$711K	0.08%	154
2022 Q3	$236K	Sell	1,200 -6,084	-84%	-$1.31M	0.01%	683
2022 Q2	$1.56M	Buy	+7,284	New	+$1.78M	0.06%	135

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Versor Investments's CRL Position: Q1 2026 in Review

Versor Investments sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 2,802 shares — an estimated $559K sold.

Versor Investments first reported a position in CRL in Q2 2022 and held it in 9 quarters. The position peaked at $1.56M in Q2 2022. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Versor Investments reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
Versor Investments sold 2,802 Charles River Laboratories shares in Q1 2026, an estimated $559K.
Versor Investments first reported a position in Charles River Laboratories in Q2 2022 and held it in 9 quarters.
Versor Investments's Charles River Laboratories position peaked at $1.56M in Q2 2022.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.